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Abstract 
Background 
Hookworm is a soil-transmitted nematode (STN) infection associated with rural poverty that 
infects 576-740 million people worldwide, 200 million of which reside in Sub-Saharan 
Africa. In 2001, the WHO passed a resolution that recommended annual deworming for 
school-aged children where the prevalence of STNs is higher than 20%. Since this time, 
albendazole has been widely used across sub-Saharan Africa to treat hookworm infection. 
Given the widespread use of albendazole as a treatment for hookworms and other STNs in 
humans, it becomes pertinent to ensure that resistance is monitored at the local level, and 
detected as it emerges. Previous research in Kintampo, Ghana found a high prevalence of low 
intensity hookworm infection prior to treatment, and raised concerns about emerging 
resistance to albendazole.  
 
Methods 
Children between the ages of 7-12 from four villages were enrolled in this study and given a 
questionnaire to gather demographic and health information about each participant (n=178). 
Fecal containers were distributed to enrolled children and the Kato-Katz technique was used 
to identify a positive infection and to estimate the severity of the infection. Children that were 
infected with hookworm were treated with a single dose of 400mg albendazole, and a second 
stool sample was collected from these children at 10-14 days post-treatment. Kato-Katz 
methods, Egg Extraction, EHA, and the Baermann method were conducted on all positive 
samples pre- and post-treatment. Genomic DNA was extracted from frozen purified 
hookworm eggs and larvae from pre- and post-treatment samples and stored for future 
testing. Molecular methods were utilized to identify the hookworm species in each sample 
Results 
At baseline, 57/178 (32.0%) of children from four villages were positive for hookworm. The 
highest prevalence was seen in Jato (43.7%), while the lowest prevalence was observed in 
Tahiru (8.0%). Post-treatment, 36.8% (21/57) of children infected at baseline were still 
hookworm positive. All of the children from Cheranda and Tahiru were cleared of infection, 
while in Mahama, one child harbored a light infection (CR=80%, FECR=97.9%). In Jato the 
cure rate was low (55.5%) and the Fecal Egg Count Reduction rate (FECR) was suboptimal 
(87.9%). Pre-treatment, almost all children harbored light infections, while all children were 
lightly infected post-treatment.  
Discussion 
These data demonstrate the need for more targeted approaches to the treatment of helminth 
infections, as variable responses are observed within each community. Findings from Jato 
suggest that in some communities, therapeutic intervention alone is not enough. Control 
measures such as health education or providing access to latrines could make a more 
substantial impact in communities like Jato, where MDA has been implemented, and where 
infection rates continue to be high among school-aged children. Data from this study further 
support the need for new approaches to combat the disease burden posed by helminth 
infections in much of the developing world.  
 
 
 
 
ii | P a g e  
 
Acknowledgments 
 
First, I would like to thank my advisors Michael Cappello and Debbie Humphries. 
They have provided me with support and guidance over the last year, and have been 
encouraging every step of the way. I would also like to thank Lisa Harrison for her guidance 
over the last year, and for teaching me the many laboratory techniques that I used in Ghana. 
Additionally, I would like to thank the Noguchi Memorial Institute for Medical Research 
(NMIMR) and the direction I received from Michael Wilson. I am grateful for the assistance 
of Joseph Otchere, Dickson Osabutey, Gertrude Ecklu-Mensah, Ryan Boyko, and all the 
other members of our summer field team for their laboratory support and expertise in 
carrying out this research. I would also like to thank Roger Fosu, Mohammed Ali, 
Mohammed Abdul Nasar and Issifu Haruna for their assistance with translation in the field 
and with the administration of consents and questionnaires. Finally, I would like to thank my 
boyfriend Scott and my family for their unconditional love over the last year, and for their 
support of my academic and professional pursuits.  I am very grateful to have each of them in 
my life. This study was supported by the Wilbur Downs International Health Fellowship, the 
Yale School of Medicine Medical Student Research Fellowship, and the Ghana-Yale 
Partnership for Global Health. 
 
 
 
 
 
iii | P a g e  
 
Table of Contents 
INTRODUCTION ..................................................................................................................... 1 
A Brief History of Hookworm Disease ............................................................................................... 1 
Hookworm Biology and Disease Pathology ....................................................................................... 2 
    Hookworm Lifecycle .......................................................................................................................... 3 
Epidemiology of Hookworm Infection ............................................................................................... 4 
Risk Factors for Infection ................................................................................................................... 6 
Disease Treatment and Management: Efficacy of Benzimidazoles and Secondary Drugs ................ 6 
An Assessment of Drug Efficacy and the Treatment of Hookworm Infection ................................... 8 
Strategies for the Control of Disease Burden ...................................................................................... 9 
Previous Study in Ghana ................................................................................................................... 11 
Study Objectives and Rationale ........................................................................................................ 12 
METHODS .............................................................................................................................. 14 
Ethical Approval and Informed Consent  ............................................................................................ 14 
Study Site  ..................................................................................................................................................... 14 
Study Participant Recruitment and Consent  ...................................................................................... 15 
Questionnaire  .............................................................................................................................................. 16 
Fecal Collection, Processing & Treatment .......................................................................................... 16 
Molecular Methods  ................................................................................................................................... 17 
Data Analysis ............................................................................................................................................... 17 
RESULTS ................................................................................................................................ 20 
Study Population ........................................................................................................................................ 20 
Baseline Characteristics of Study Population  ................................................................................... 21 
Prevalence and Intensity of Intestinal Helminths at Baseline  ...................................................... 23 
Prevalence and Intensity of Hookworm Infection at Baseline  ..................................................... 23 
iv | P a g e  
 
Demographic and Socioeconomic Analysis of the Baseline Study Population by Infection 
Status  ............................................................................................................................................................. 27 
Risk Factors for Hookworm Infection at Baseline  .......................................................................... 30 
Post treatment Demographic and Socioeconomic Assessment Based on                       
Treatment Response   ................................................................................................................................ 31 
Cure Rate and Fecal Egg Reduction Rate  .......................................................................................... 33 
In vitro Susceptibility of Hookworm Isolates  ................................................................................... 34 
Identification of Hookworm Species Using PCR  ............................................................................ 36 
DISCUSSION .......................................................................................................................... 37 
REFERENCES ........................................................................................................................ 44 
APPENDICIES ........................................................................................................................... I 
Appendix 1: Ghana Questionnaire, Summer 2013  ............................................................................. I 
Appendix 2: Egg Extraction Protocol  .................................................................................................. VI 
Appendix 3: Baermann Funnel Set-up .............................................................................................. VIII 
Appendix 4: Egg Hatch Assay (EHA)  ................................................................................................ IX 
 
 
 
  
 
 
 
 
 
 
 
v | P a g e  
 
Figures 
 
Figure 1: Life Cycle of Human Hookworms .................................................................................... 3 
Figure 2: Global Distribution of Human Hookworm Infection  .................................................. 5 
Figure 3: Hookworm and Schistosome Mono- and Co-infections in Ghana among Children 
ages 5-19 .............................................................................................................................................. 11 
 
Figure 4: The Techiman-Tamale Highway in Kintampo North Municipality, Ghana ............. 15 
 
Figure 5: Characteristics of Study Population  ............................................................................... 20 
Figure 6: Absolute Wealth Index by Village .................................................................................. 22 
Figure 7: Prevalence of Intestinal Helminth Infections at Baseline  ........................................... 23 
Figure 8: Prevalence of Intestinal Helminth Infections at Baseline by Village ......................... 24 
Figure 9: Intestinal Helminth Mono- and Co-infection at Baseline (n=178) ............................. 25 
Figure 10: Pre-treatment Hookworm Prevalence by Village ....................................................... 26 
Figure 11: Community Variation in Response to Treatment  ...................................................... 33 
Figure 12: Susceptibility of Hookworm eggs to Albendazole at Increasing Concentrations 
Before and After Treatment .............................................................................................................. 35 
 
Tables 
 
Table 1: Demographic and Socioeconomic Indicators of the Study                             
Population at Baseline ....................................................................................................................... 21 
Table 2. Intensity of Hookworm Infection at Baseline ................................................................. 26 
Table 3: Demographic and Socioeconomic Indicators of the Study                                
Population by Hookworm Infection Status at Baseline................................................................. 28 
Table 4. Host Factors of the Study Population by Hookworm Infection Status at Baseline .... 29 
Table 5.  Risk Factors for Hookworm Infection at Baseline ........................................................ 30 
Table 6. Demographic and Socioeconomic Indicators of the Treatment Population by Post-
Treatment Hookworm Infection Status ........................................................................................... 31 
Table 7. Host Indicators of the Treatment Population by Post-Treatment Hookworm Infection 
Status .................................................................................................................................................... 32 
Table 8. Hookworm Cure Rate and Egg Reduction Rate of the Treatment Group ................... 33 
 
1 | P a g e  
 
I. Introduction 
 
a. A Brief History of Hookworm Disease 
 
Today a disease of rural poverty, hookworm infection has been observed in humans for 
over 5,000 years (Cox 2002). The earliest written record of hookworm infection is commonly 
ascribed to the Ebers papyrus of 1500 B.C., when an anemia like condition that caused pallor 
and laziness was described (Cox 2002).  Records from 300 B.C. depict hookworm infection 
as a disease that is characterized by intestinal distress and a tendency to eat dirt (Power 
2001). Similar descriptions of a disease associated with pallor and weakness appear in the 
writing of Lucretius in 50 B.C., and in references from China in the third century(Cox 2002). 
An increasing number of references to the suspected disease appeared in records from 
European explorers in the West Indies and South and Central America in the 18th-19th 
centuries (Cox 2002). 
Italian physician Angelo Dubini first identified one species of hookworm, Ancylostoma 
duodenale, in 1838, where he observed that it used its teeth to attach to the intestinal lining 
(Power 2001). Building off his work, Wilhelm Griesinger drew a connection between the 
worms and iron deficiency anemia during autopsies in 1854 (Cox 2002). While examining 
feces with microscopy in 1878, Giovanni B. Grassi developed the first diagnostic method for 
examining hookworm ova, and the first anthelminthic drug, thymol, was developed shortly 
thereafter (Power 2001). Just two years later, Edoardo Perroncito correlated an anemia 
outbreak among miners in the St. Gothard tunnel with hookworm infection, after noting in 
autopsies that a high number of hookworms correlated with the symptoms of anemia (Power 
2001). Finally, in the early 20th century, a second species of hookworm, Necator americanus 
was identified among agricultural laborers in Puerto Rico. Shortly thereafter, Arthur Loos 
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discovered how hookworms enter the body and reach the small intestine after accidently 
infecting himself (Power 2001, Cox 2002). 
 
b. Hookworm Biology and Disease Pathology 
 
Human hookworm infection is a parasitic disease caused by two types of blood sucking, 
soil-transmitted nematodes (STNs): Ancylostoma duodenale and Necator americanus (Hotez 
P. 2005). Symptoms of infection vary, and typically begin with itching and a localized rash 
that results when larvae penetrate the skin. Although most infections with hookworm are 
asymptomatic (especially light infections), symptoms may include abdominal discomfort, 
fatigue, weight loss, anemia and protein deficiencies. Heavy infection can result in the 
impairment of physical and cognitive development, especially among children, who can lose 
up to 20mls of blood each day as a result of infection (Humphries D 2012, Bird, Ame et al. 
2014). 
Although infection with hookworm is rarely fatal, it can often increase susceptibility to 
other STNs such as trichuriasis, and diseases such as malaria, HIV and tuberculosis 
(Humphries D 2013). The impact of hookworm infection on the host, and the level of anemia 
that results are typically dependent on a variety of factors. The worm burden plays a role in 
influencing the severity of disease, as does the hosts’ nutritional status. Iron reserves and diet 
play a key role in the severity of disease, making the infection more detrimental among 
children that are malnourished. The species of hookworm also plays a role in the severity of 
disease, due to the fact that A. duodenale typically causes more blood loss than N. 
americanus (Brooker S 2004). 
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c. Hookworm Lifecycle 
 
When hookworm eggs are passed in the stool, under certain conditions (such as shade, 
moisture and warmth) the eggs will hatch over a period of 1 to 2 days ((CDC) 2013). Over a 
period of 5-10 days, the hatched larvae undergo two molts, after which time they become 
infectious filariform third-stage larvae (L3) ((CDC) 2013).Under the right environmental 
conditions, these larvae can live in the soil for as long as 4 weeks ((CDC) 2013). 
Figure 1: Life Cycle of Human Hookworms 
 
 
Humans typically become infected with hookworm when skin comes into contact with L3 
larvae in the soil, although A. duodenale L3 have been shown to infect by both the skin and 
oral route (Hotez P 2004). Following host entry, L3 are carried by blood vessels to the heart 
and then on to the lungs over a period of approximately ten days ((CDC) 2013). L3 enter the 
digestive system by penetrating the pulmonary alveoli and ascending to the trachea, where 
they are coughed up and swallowed (Hotez P. 2005, Bungiro R 2011). Upon entering the 
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gastrointestinal tract, hookworms undergo two molts, after which time they reach the adult 
blood feeding stage (Hotez P 2004).  After using their teeth to attach to the intestinal mucosa 
in the lumen of the small intestine, they begin feeding on tissue and blood (Hotez P. 2005, 
Bungiro R 2011). Once adhered to the small intestine, adult hookworms mate and begin 
producing eggs, which are then excreted in the feces (Hotez P. 2005, Bungiro R 2011). 
Following excretion, the hookworm eggs in the stool are released into the environment, and 
can thereby repeat the parent life cycle (Hotez P. 2005, Bungiro R 2011) (Figure 1). 
 
d. Epidemiology of Hookworm Infection 
Although hookworm infection has been eliminated from more developed nations, 
infection is still highly prevalent in many parts of the developing world, especially among 
school-aged children (SAC). It has been estimated that there are still an estimated 740 
million people infected with hookworm around the world, with more disability adjusted life 
years (DALYs) lost than any other helminth infection except lymphatic filariasis (Hotez P 
2006). Higher prevalences of disease are observed in tropics and subtropics, and highest in 
rural areas (Brooker S 2004). Although it is more common to see the highest intensities of 
STN infections among children, both children and adults are frequently heavily infected 
with hookworm (Hotez P. 2005). 
Infection with N. americanus has been shown to be more widespread, while infection 
with A. duodenale has been shown to be more focalized (Hotez P. 2005). Infection with N. 
americanus is seen throughout the world, in regions such as South and Southwest China, 
Southeast asia, Southern India, sub-Saharan Africa, and South and Central America 
(Brooker S 2004). In contrast, A. duodenale is predominantly found in regions with harsher 
environmental conditions, where it is less likely for N. americanus to survive (Brooker S 
2004). These regions include the northern parts of southern India, southern and western 
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China, and a few parts of Latin America (Northern Argentina, Paraguay) and Northern 
Australia (Hotez P. 2005). 
Figure 2: Global Distribution of Human Hookworm Infection 
 
 
Hotez PJ, Bethony J, Bottazzi ME, Brooker S, et al. (2005) Hookworm: “The Great Infection of 
Mankind”. PLoS Med 2(3): e67. 
 
While hookworm infection can be found in much of the developing world, rates vary 
by region (Figure 2). Central and South America see the lowest prevalence of disease (10%), 
followed by China and south Asia (16%) and southeast Asia (26%) (Humphries D 2012). The 
highest prevalence and intensity of infections are observed in Sub-Saharan Africa (29%), 
where there are an estimated 200 million cases (Brooker S 2004, Humphries D 2011).  While 
improvements in socioeconomic status, water, sanitation, and control efforts have decreased 
the disease burden in other parts of the world such as Latin America, there has been little 
change in the prevalence of hookworm in Sub-Saharan Africa (Brooker S 2004). In Ghana, 
some regions see a prevalence of infection that exceeds 87.5%, while rates of infection 
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among school aged children in Kintampo have been reported to be around 45% (Ziem J 2006, 
Humphries D 2011).  
 
e. Risk Factors for Infection 
 
 Hookworm infection transmission is dependent upon environmental contamination 
with hookworm eggs. As such, infection with hookworm is often influenced by 
socioeconomic status. Limited access to clean water, sanitation and adequate health care, 
along with poor education provide an environment under which transmission can continue 
(Hotez P 2004). Working in agriculture, a common occupation in much of the developing 
world, has been shown to be associated with infection, especially in areas where waste water 
or night soil is regularly used to enhance agricultural production (de Silva 2003). Inadequate 
hygiene practices and the absence of latrines and sewage treatment have also been shown to 
be associated with infection (Raso, Vounatsou et al. 2006). Not wearing shoes is also 
associated with elevated rates of infection, and poor nutritional status, malaria, and anemia 
prior to infection are known to exacerbate the effects of the disease (Hotez P 2004). 
 
f. Disease Treatment and Management: Efficacy of Benzimidazoles and Secondary 
Drugs 
 
The main class of drugs used to treat soil-transmitted helminthes, including 
hookworm infections, is the benzimidazoles. These drugs bind to the tubulin protein of 
microtubules, which are important organelles involved in cell motility and division (Keiser J 
2010). By binding to these organelles, the uptake of glucose is blocked, which ultimately 
empties glycogen reserves in the parasite (J 2002). Depleted of energy, the worm is then 
expelled from its host, or is paralyzed and dies (J 2002). Although lethal to the parasite, these 
drugs are generally well tolerated by the host (J 2002). This is because they have a higher 
affinity for binding to tubulin in the worm than in humans or livestock (J 2002). Although 
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considerably effective at treating many types of worm infections, these drugs are quickly 
excreted from the body and do not provide any protection against reinfection (J 2000).  
 Albendazole, a drug in the class of benzimidazoles, is the primary drug 
recommended for the treatment of hookworm infection. Approved for human use in 1987, 
albendazole is administered orally and can be used to treat a variety of worm infections, 
including ascariasis, trichuriasis, enterobiasis and hookworm (Keiser J 2010). In a recent 
review conducted by Keiser and Utzinger, 11 different studies showed that albendazole 
therapy was well tolerated, and that there were no significant adverse events reported 
following albendazole administration (Keiser J 2008). However, mild symptoms including 
dizziness, headache, nausea, vomiting, and abdominal pain have been reported in response to 
treatment with a single dose of albendazole (Keiser J 2010). 
Mebendazole is another benzimidazole that can be used to treat hookworm infection, 
although the drug is not as effective at treating hookworm as albendazole (Keiser J 2010). 
Like many other benzimidazoles, mebendazole is administered in a single dose and targets 
the tubulin in the parasite cell (Keiser and Utzinger 2008).  Although mebendazole is less 
effective in the treatment of hookworm infection, it has a high efficacy in the treatment of 
Ascaris (Keiser and Utzinger 2008).  
Pyrantel pamoate acts as a nicotinic acetylcholine receptor antagonist in the parasite 
(Keiser J 2010). By doing so, it causes spastic paralysis of the worm, ultimately leading to 
death.(Keiser J 2010) Although it is a second line drug for hookworm, pyrantel pamoate is 
more commonly used in the treatment of ascariasis and enterobiasis, with cure rates of 90-
100% (Keiser and Utzinger 2008). In a review examining its efficacy in treating hookworm 
infection, nearly half of patients in one trial experienced adverse events such as nausea, 
dizziness and abdominal pain (Keiser and Utzinger 2008). Similar to pyrantel pamoate, 
levamisole targets the acetylcholine receptor within the parasite, ultimately leading to the 
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paralysis and death of the worm. Levamisole is associated with a diverse array of side effects 
including vomiting, diarrhea, dizziness, and headache (Mehlorn 2008). Given the higher risk 
of adverse events, these drugs are recommended only as second line drugs for the treatment 
of hookworm infection (Keiser and Utzinger 2008). 
 
g. An Assessment of Drug Efficacy and the Treatment of Hookworm Infection 
When examining the efficacy of these drugs against hookworm in 20 randomized 
controlled trials, a single dose of 400 mg albendazole was found to have an overall cure rate 
of 72%, while mebendazole had a cure rate of 15% and pyrantel had a cure rate of 32% 
(Keiser J 2008). Levamisole treatment in several trials had cure rates between 10%-38% 
(Keiser J 2008). This study went on to conclude that, when administered as a single-dose 
therapy, albendazole reduced the prevalence of hookworm more effectively than any other 
drug (Keiser J 2008). Although albendazole is the primary therapy used to treat hookworm 
infection, pyrantel pamoate and levamisole are considered to be alternative treatments for 
hookworm (Keiser J 2008).  Despite the low cure rate for mebendazole therapy, it is still 
widely used to treat hookworm (Keiser J 2008). In Ghana, between 4-5 million children are 
still treated with mebendazole therapy each year, despite its low cure rate (Keiser J 2008).   
 There have been several studies that have examined the decreasing susceptibility of 
parasitic worms to anthelmintic drugs in livestock. A recent study conducted in Uganda 
observed very low efficacy for albendazole therapy (28.5%) when treating goats for 
gastrointestinal nemotodes (Byaruhanga C 2013). Another study conducted in Northern 
Ireland examined treatment efficacy for several benzimidazoles used to treat flocks of sheep, 
and found significant resistance to one or more of these drugs in 81% of blocks tested 
(McMahon C 2013). In a 2010 study, Vercruysse points out that many years of using 
anthelminthic drugs to control roundworms in livestock resulted in high levels of resistance 
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to the drugs (Vercruysse J 2011). Later, he mentions that treatment frequency and possible 
under-dosing have been identified as contributors to the development of drug resistance 
(Vercruysse J 2011).  
Although albendazole therapy has become the standard course of treatment for 
hookworm infection in humans, there have been reports that have brought up the possibility 
of a decreasing susceptibility to the drug. A study conducted in Laos in 2010 noted that 
albendazole therapy had a cure rate of 36%, far less than the cure rate seen in the majority of 
studies (Soukhathammavong P 2012). While they concluded that differences in hookworm 
species susceptibilities, host factors, and co-infection with other STNs could play a role in 
treatment failure, the possibility of increasing resistance to albendazole could not be ruled out 
(Soukhathammavong P 2012). Two trials conducted in Vietnam in 2007 found that single-
dose albendazole was no more effective against hookworm than a placebo, and noted that 
only a three-dose regimen of albendazole was more effective at treating hookworm than the 
placebo (Flohr C 2007). 
 
h. Strategies for the Control of Disease Burden 
 
At the turn of the 20th century, hookworm disease, commonly referred to as a “disease 
of laziness” was widespread across the southern United States (Bleakley 2007). After 
realizing the serious public health problem that hookworm disease posed in this region, the 
Rockefeller Foundation founded the Rockefeller Sanitary Commission (RSC) for the 
eradication of hookworm disease, and initiated a campaign from 1910-1915 (Brooker S 2004, 
Bleakley 2007). This campaign used a multifaceted approach to decrease the burden of the 
disease, involving treatment, education, and latrine building across the southern United States 
(Bleakley 2007). At the start of the campaign, the RSC surveyed over 600 counties across the 
south and found that the prevalence of disease among school aged children in the American 
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South averaged 43% (Bleakley 2007, M 2009). Following this observation, the RSC built 
latrines and created traveling treatment dispensaries that provided thymol to nearly 400,000 
individuals over the course of the campaign (Power 2001, Bleakley 2007, M 2009). At the 
same time, the RSC initiated an educational campaign to inform both the public and local 
physicians about hygiene practices and how to recognize and prevent infection (Bleakley 
2007). Although these strategies failed to eliminate hookworm disease from the southern 
United States, this multifaceted approach resulted in a 50% decrease in the prevalence of the 
disease (Bleakley 2007). As the RSC’s campaign came to a close, local and state 
governments began to fund anti-hookworm campaigns, and took over many of the 
foundations activities (Bleakley 2007, M 2009). As result of this campaign and the growing 
awareness that ensued, hookworm disease experienced a significant decline in the southern 
United States that ultimately led to its elimination from the region (M 2009).   
Although hookworm infection still exists in much of the developing world, this 
campaign demonstrated that a combination of education, infrastructure development and 
therapy can make a significant difference in the prevalence of hookworm infection.  
In an attempt to alleviate the disease burden in the developing world, the World Health 
Organization passed a resolution in 2001 at the 54th World Health Assembly to control 
infection (Humphries D 2012). This resolution urged “member states to provide regular drug 
treatment of high-risk groups,” with the overarching goal of reaching at least 75% of school 
aged, at risk children by 2010 (Humphries D 2012). This resolution went on to recommend 
annual deworming in areas where the prevalence of STNs was higher than 20%.(Humphries 
D 2012) In an effort to control morbidity, the WHO launched a project to control soil 
transmission, which was first initiated in Asia (2004), East Africa (2005) and West Africa 
(2006) (Jiraanankul, Aphijirawat et al. 2011).  As of 2013, the WHO continued to 
recommend annual or biannual treatment in endemic regions, with a focus on increasing 
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coverage in regions that did not meet coverage criteria. Alongside mass drug administration, 
improvements in water, sanitation, and socioeconomic status in Asia and Latin America have 
contributed to a decrease in the overall prevalence of hookworm infection (Brooker S 2004). 
However, rates of infection in sub-Saharan Africa continue to be high, as poor education, 
limited access to adequate health care, and unsanitary living conditions continue to provide 
conditions which favor transmission (Bungiro R 2011). 
 
i. Previous Study in Ghana 
 
Previous studies have found a high degree of variability of hookworm prevalence 
across Ghana. A cross-sectional study conducted throughout Ghana in 2011 found the 
prevalence of hookworm infection to be highly focal, with cases observed in mostly Central 
and Northern Ghana (Figure 2) (Soares Magalhaes, Biritwum et al. 2011).  
Figure 3: Hookworm and Schistosome Mono- and Co-infections in Ghana Among Children 
ages 5-19 
 
Soares Magalhaes, R. J., et al. (2011). "Mapping helminth co-infection and co-intensity: 
geostatistical prediction in ghana." PLoS Negl Trop Dis 5(6): e1200. 
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A recent study conducted in Southern Ghana found a higher prevalence of infection in 
rural areas than in urban areas (13.6% vs. 0.1%), while a study conducted in the Volta region 
of Eastern Ghana found a 9.8% prevalence (van Mens, Aryeetey et al. 2013, Egbi, Steiner-
Asiedu et al. 2014). In a study examining over 20,000 participants from 216 villages in 
Northern Ghana, all but one village (99.5%) had at least one case of hookworm present, with 
an overall prevalence of 50% (Yelifari, Bloch et al. 2005). Most studies found that 
participants were predominantly infected with Necator americanus, although Anclystoma 
duodenale was found in 20% of participants (de Gruijter, van Lieshout et al. 2005, Soares 
Magalhaes, Biritwum et al. 2011). 
Previous research in Kintampo found a high prevalence of low intensity hookworm 
infections in Kintampo North prior to treatment (Humphries D 2012). Data from 2007 across 
four communities found a cure rate of 61% following administration of single dose 
albendazole therapy (Humphries D 2012). The fecal egg count reduction (FECR) rate was 
below the 90% mark for an effective therapy, at 82% (Humphries D 2012). A study of 16 
schools in 13 communities in Kintampo in 2010 again found sub-optimal cure rate (44%) and 
FECR rate (87%) (Humphries D 2012). A 2011 study in five contiguous Kintampo 
communities again noted sub-optimal cure (37.2%) and FECR rate (60.4%) (Humphries D 
2012). While the cure rate and FECR rate were relatively low in this study, albendazole 
response was highly variable across the five communities (Humphries D 2012). Most 
recently, study in Kintampo found a 39% prevalence of infection with a 43% cure rate and 
FECR rate of 87.3% after one dose of albendazole (Humphries D 2013). Given the 
moderately low cure rates and FECR rate observed in these studies, further investigation is 
warranted in order to ensure that resistance is observed as it arises.  
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j. Study Rationale and Objectives 
The emergence of reduced albendazole efficacy for hookworm infection has major 
worldwide implications. We hypothesized that the decreasing effectiveness of albendazole 
therapy was due to reduced susceptibility of the parasite. This  study  provides  important  
data  about  parasitic  factors  that  may  be contributing to a decrease in albendazole 
susceptibility. In order to evaluate this hypothesis, the primary objectives of this study were 
to: 
1. Determine the baseline prevalence, intensity, and epidemiology of hookworm 
infection in four villages in Kintampo North Municipality. These villages (Jato, 
Cheranda, Mahama and Tahiru) previously exhibited high and low cure rates 
following albendazole therapy. 
2. Determine the relationship between clinical response and in vitro albendazole 
susceptibility using human hookworm isolates. 
3. Extract  genomic  DNA  for  future  studies  aimed  at  defining  the  molecular  
basis of albendazole resistance in Kintampo North. 
4. Identify the species of hookworm from each positive sample 
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II. Methods 
a. Ethical Approval and Informed Consent 
 
The Yale University Human Investigation Committee (HIC) approved both field and 
laboratory components of this project in May, 2013 under protocol number 1304011926. 
Approval was also given by the Noguchi Memorial Institute for Medical Research (NMIMR) 
investigational review board (IRB), the Ghanaian Ministries of Health and Education, the 
Kintampo Health Research Centre (KHRC), the chiefs and elders of each community and the 
teachers and directions from each school.                                      
Preliminary steps to begin recruiting participants began in May, 2013 when the 
research team initiated meetings to discuss the study protocol with directors at the Ministry of 
Health and Education and the Kintampo Health Research Center. After reviewing census data 
compiled in November 2012, it was determined that 226 children from 4 villages along the 
Techiman-Tamale highway north of Kintampo were eligible to be recruited for this study. 
Study subjects were included in the study if they: 1) resided within the study area, 2) were 
between the ages of 7-12, and 3) were willing and able to give consent. Children were 
excluded from the study if they were already enrolled in an ongoing longitudinal study 
conducted by colleagues at the NMIMR. Under the approved protocol, every child that met 
entry criteria would be asked to enroll in the study. 
 
 
b. Study Site: 
  
This study was conducted between May and July, 2013 along a 30km stretch of the 
Techiman-Tamale highway in Kintampo North Municipality, Ghana, between Tahiru (the 
southernmost village) and Cheranda (the northern most village) (Figure 1). Kintampo is part 
of the Brong Ahafo region of central Ghana, which predominantly agricultural, and cocoa, 
yam and cassava are frequently grown in this region. Farming is the most common 
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occupation, and sanitation and access to clean water are limited. Helminth infections are 
highly prevalent, especially among primary school children. 
 
Figure 4: The Techiman-Tamale Highway in Kintampo North Municipality, Ghana 
 
 
 
 
 
c. Study Participant Recruitment and Consent: 
 
Meetings were initiated with local chiefs and elders in each village in order to discuss 
the study. Following approval, community meetings were set up in order to explain the 
purposes of the study to all interested parties in each village. All meeting were conducted by 
Ghanaian colleagues in the local language, Twi, to ensure that the study purposes were 
clearly understood. Following community meetings in each of the villages, potential study 
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participants were visited at their homes. Ghanaian colleagues reiterated the purposes of the 
study in Twi to children and their parents. For those that agreed to participate, written consent 
forms were signed by the child and their parent and a copy of the consent form was given to 
all enrolled participants for reference. After visiting the homes of all potential participants, 
the final study population consisted of 179 children ages 7-12 from 4 separate villages: Jato, 
Cheranda, Mahama and Tahiru. 
 
 
d. Questionnaire               
                                                                       
Upon enrollment into the study, the parent or guardian of each study participant was 
given a household questionnaire by two assistants from the Kintampo Health Research 
Center. This questionnaire contained questions that were included in a more extensive 
questionnaire conducted in January, 2013 when the community census took place. Interviews 
were conducted in Twi, and gathered information about the child’s school and community, 
along with information about the household in which they lived. This assessment provided 
information about potential confounders including basic information about the child, age, 
socioeconomic status, and any environmental exposures that may have varied from household 
to household (Appendix 1). 
 
 
e. Fecal Collection, Processing & Treatment: 
 
              Following consent, 500ml fecal collection cups were administered to each study 
participant. Children were instructed to fill the cups with fresh portions of their morning 
stool, and the following day, cups were collected from each child and taken back to the 
Kintampo Health Research Center in a cooler. The Kato-Katz technique was used in 
duplicate for each sample in order to identify a positive infection.(Katz N 1972) Laboratory 
personnel identified the presence or absence of parasite ova through the use of microscopy 
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and the number of eggs were counted on both slides and averaged. In order to calculate the 
total number of eggs per gram, the average was multiplied by a factor of 24. All samples that 
had at least one hookworm ova present were set aside for further processing. In addition to 
examining slides for hookworm ova, slides were counted for Ascaris lumbricoides, Trichuris 
trichiura, Taenia spp., and Hymenolepis nana and counts were recorded for future reference. 
A small amount of stool was set aside from each positive sample and pooled together 
by village. Each pool was used in the Baermann method (Appendix 3) in order to hatch 
hookworm ova and isolate hookworm larvae for future analysis. Hookworm ova were 
extracted from the remaining stool for each infected study participant (Appendix 2), and egg 
hatch assays were set up for samples that had a high enough number of eggs in order to 
measure pre-treatment susceptibility to albendazole (Appendix 4). The remaining extracted 
eggs were frozen in the lab for future analysis.  
 Each child that was positive for hookworm was treated with a single dose of 400mg 
albendazole within a week of laboratory diagnosis. Ten to fourteen days after treatment, a 
second stool sample was collected and the Kato-Katz technique was again repeated in order 
to identify positive infections. Egg extractions, Egg Hatch Assays and the Baermann method 
were conducted for all positive post-treatment samples and eggs were frozen for future 
analysis. Children that were infected with hookworm post-treatment were given an additional 
dose of 400mg albendazole within a week of identification. At this time, children with other 
parasitic infections were also treated with albendazole (T. trichiura) or praziquantel (H. 
nana). 
 
f. Molecular Methods: 
 
            Following the completion of post-treatment collections, genomic DNA was extracted 
at the Kintampo Health Research Center from all pre- and post-treatment eggs using the 
QIAamp DNA stool Kit (Qiagen). Larvae samples were pelleted down, and both extracted 
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DNA from eggs and pelleted larvae were taken back to the Cappello laboratory for future 
analysis.  
Starting in September of 2013, the Cox-1 polymerase chain reaction (PCR) protocol 
was used in order to determine which species of hookworm (Necator americanus or 
Ancylostoma duodenale) was present in samples. PCR products for both NA and AD were 
used in gel electrophoresis, and those with visible product were extracted in order to obtain 
purified DNA. Purified DNA was combined with primer and TBE buffer and sent to a lab at 
the Yale School of Medicine for sequencing. Sequences were returned for each product and 
BLASTed on the NCBI database. This was done in order to see if sequences matched other 
Necator americanus or Ancylostoma duodenale isolates within the database. Those that were 
matches were noted as confirmed cases of either subtype. 
 
g. Data Analysis: 
 
There are three measurements that were calculated to access drug effectiveness: the 
fecal egg count reduction rate (FECR), the cure rate (CR), and the hatch rate (HR) 
(Vercruysse J 2011). While the cure rate tells us about the change in the prevalence of the 
disease, the egg reduction rate tells us the percentage decrease from baseline to post-
treatment levels (Anantaphruti M 2007). The hatch rate calculates in vitro susceptibility of 
hookworm eggs to albendazole. 
 
FECR = 
Mean EPG 𝑏𝑒𝑓𝑜𝑟𝑒 deworming−Mean EPG 𝑎𝑓𝑡𝑒𝑟 deworming
Mean EPG 𝑏𝑒𝑓𝑜𝑟𝑒 deworming
∗ 100% 
 
CR = 
% Prevalence 𝑏𝑒𝑓𝑜𝑟𝑒 treatment−% Prevalence 𝑎𝑓𝑡𝑒𝑟 treatment
% Prevalence 𝑏𝑒𝑓𝑜𝑟𝑒 treatment
∗ 100% 
 
HR = 
number of hatched larvae
number of hatched larvae+number of remaining eggs
∗ 100% 
 
At the conclusion of the study, the CR and FECR were compared between the two 
villages. Those individuals that were still excreting eggs in their stool (treatment failures) 
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were given another dose of 400 mg albendazole. Only study subjects with complete data 
sets were included in the analysis stage. Data was stored in Microsoft Excel, and statistical 
analysis was conducted with SAS version 9.3.  Descriptive statistics detailing 
demographics, socioeconomic status, nutritional status, and hookworm infection intensity 
were also calculated for the two groups of children. Univariate statistical analyses of pre- 
and post-treatment study populations will be used for descriptive purposes. The Chi-
Squared test was used to examine differences between populations and groups, while T-
tests were used for continuous variables. Unadjusted logistic regression was used to identify 
explanatory variables, which were then used in multivariate analysis. This statistical 
technique allowed for the assessment of any factors that could be mediating decreased 
albendazole susceptibility. 
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III. Results 
 
a. Study Population: 
At the time of enrollment, 226 children were eligible in the four communities to enroll 
in the study. Of these, 179 were enrolled in the study and fecal samples were received from a 
total of 178 children. Fifty-seven children were hookworm positive after baseline collections, 
while 121 children were negative for hookworm infection. All 57 children that were 
hookworm positive at baseline were treated with a single dose of 400mg albendazole. Post-
treatment (10-14 days) samples were received from all 57 children. Of these, 36 children 
fully responded to treatment and were hookworm negative, while 21 children were still 
positive for hookworm infection.  
Figure 5: Characteristics of Study Population  
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b. Baseline Characteristics of Study Population: 
aTable values are column % (N) for categorical variables and mean + SD for continuous 
variables  
bNumbers may not sum to total due to missing data and percentages may not sum to 100% 
due to rounding 
 
 
Initial analysis of the baseline population was done with univariate statistics in SAS v. 
9.3. The average age of children enrolled (n=178) was 9.5 years old. Eighty-nine (50%) study 
participants were male while 89 (50%) were female. Children had an average body mass 
index of 16.75 and only 8 children (4.49%) did not attend school. There were approximately 
12 people per household, and the majority of households owned agricultural land (81.5%) 
Table 1. Demographic and Socioeconomic Indicators of the Study Population at Baseline 
Characteristic Study Population (N = 178)b 
Age (years) 9.45 ± 1.72 
Sex  
   Female 50 (89) 
   Male 50 (89) 
Body Mass Index 16.75 ± 4.1 
Average Household Size 11.54 ± 6.94 
Absolute Wealth  
   Low                                           33.15 (59) 
   Middle                                           42.70 (76) 
   High 24.16 (43) 
Ownership of  agricultural land  
    Yes 81.46 (145) 
    No 18.54  (33) 
Household savings account  
    Yes 52.25 (93) 
     No 47.75 (85) 
Daily use of a Latrine or Toilet  
     Yes 21.91 (39) 
     No 78.09 (139) 
Primary Religion  
     Muslim 12.92 (23) 
     Christian 70.22 (125) 
     Traditional  12.36 (22) 
     Other 4.49 (8) 
Attends School  
     Yes 95.51 (170) 
     No 4.49 (8) 
Daily Shoe Usage  
    Yes 82.58 (147) 
     No 0.17 (31) 
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and were Christian (70.22%). Most children had daily access to a toilet or latrine (78.09%) 
and wore shoes daily (82.58%). 
An absolute wealth index was calculated using data from 18 measurements in order to 
estimate the approximate wealth of each household.(Filmer and Pritchett 2001) This measure 
of socioeconomic status included a variety of variables from the household questionnaire 
(ownership of pigs, poultry, goats or sheep, horses or donkeys, a tile floor, use of advanced 
cooking fuel, electricity, radio, TV, phone, refrigerator, bike, car or motorcycle, ownership of 
land,a bank or savings account, improved water source, and an improved toilet ) in order to 
compare absolute wealth at the community level.(Filmer and Pritchett 2001, Humphries D 
2013) The mean absolute wealth index across the study was 6.08 with a standard deviation of 
2.065. Children from Mahama had the lowest absolute wealth index (5.667), while children 
in Jato had the highest absolute wealth index (6.437). 
  
Figure 6: Absolute Wealth Index by Village 
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c. Prevalence of Intestinal Helminth Infections at Baseline: 
After screening, the highest prevalence of Helminth infection was hookworm 
infection, which occurred in 32.02% of study participants (n=57) (Figure 6). Trichuris 
trichiura was observed among 1.12% of study participants (n=2) while Hymenolepis nana 
was found among 12.92% (n=23) study participants (Figure 6). Although fecal smears were 
examined for Ascaris lumbricoides and Taenia saginata, no cases were detected among study 
participants at baseline.  
 
Figure 7: Prevalence of Intestinal Helminth Infections at Baseline 
 
 
Hookworm infection was found in all four communities (figure 7) with varying levels 
of infection. T. trichiura was observed only in Cheranda, while H. nana was observed across 
all four communities, with the highest prevalence in Mahama, where 25% of study 
participants were infected. No cases of A lumbricoides or T. saginata were observed among 
study participants at baseline.  
0.3202
0.0112 0.0000 0.0000
0.1292
0.0000
0.0500
0.1000
0.1500
0.2000
0.2500
0.3000
0.3500
Hookworm Trichuris
trichiura
Ascaris
lumbricoides
Taenia saginata Hymenolepis
nana
P
R
EV
A
LE
N
C
E 
(%
)
HELMINTH INFECTION
24 | P a g e  
 
 
Figure 8: Prevalence of Intestinal Helminth Infections at Baseline by Villagea 
 
aAscaris lumbricoide and Taenia saginata excluded due to 0% prevalence among study 
participants 
 
Out of a a possible 178 study participants,  103 (57.87%) had no visible helminth eggs 
of any species in their stool (Figure 8). Few (1.12%) subjects were positive for T. trichiura, 
while 8.99% (n=16) of participants were positive for only H. nana (Figure 8). Isolated 
hookworm monoinfection was observd in 23.09% of participants (n=50), while 3.93% (n=7) 
of participants were co-infected with hookworm and H. nana. 
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Figure 9: Intestinal Helminth Mono- and Co-infection at Baseline (n=178) 
 
 
d. Prevalence & Intensity of Hookworm Infection at Baseline: 
After collecting initial baseline stool samples from each of the study participants, a 
total of 57 children from all four communities were positive for hookworm.  While 3.51% of 
hookworm positive cases were from Tahiru (N=2), 8.77% of cases (N=5) each came from 
Mahama and Cheranda, and 78.95% of cases (N=45) were from Jato (Figure 3). Although the 
highest number of cases came from Jato, both Jato and Mahama had high prevalences of 
hookworm (43.69% and 42.67% respectively) while Tahiru (8.00%) had the lowest 
prevalence (Figure 3).   
 
 
57.87%28.09%
1.12%
8.99%
3.93%
None
Hookworm
Trichuris trichiura
Hymenolepis nana
Co-infection (Hookworm and Hymenolepis nana)
26 | P a g e  
 
Figure 10: Pre-treatment Hookworm Prevalence by Village 
 
 
Almost all cases (98.25%) were characterized as having a light infection (Table 2). 
Only one child from Jato was noted to have a heavy infection of over 4000 eggs per gram 
(EPG). Children that were infected at baseline had a mean egg count of 443epg, and egg 
counts ranged from 12-6336epg among the sample of children positive at baseline (Table 2).  
 
Table 2. Intensity of Hookworm Infection at Baseline  
Classificationa N (%)b    
     Light (1-1,999 Eggs per gram) 56 (98.25)    
     Moderate (2,000-3,999 Eggs per gram) 0 (0)    
     Heavy (>4000 Eggs per gram) 1 (1.75)    
aBased on WHO criteria (Pawlowski Z 1991) 
 
 
0.1316
0.4369
0.4167
0.0800
0.0000
0.0500
0.1000
0.1500
0.2000
0.2500
0.3000
0.3500
0.4000
0.4500
0.5000
Cheranda Jato Mahama Tahiru
P
re
-t
re
at
m
en
t 
H
o
o
kw
o
rm
 P
re
va
le
n
ce
 (
%
)
Village
27 | P a g e  
 
e. Demographic and Socioeconomic Analysis of the Baseline Study Population by Infection 
Status 
 
After collecting and processing all stool samples, univariate statistics were computed 
for a variety of variables based on hookworm infection at baseline. Continuous variables 
were analyzed using t-tests while chi-squared tests were used for categorical and binary 
variables. Children that were positive at baseline were slightly younger (9.13 years old) 
than those that were uninfected (9.69 years old), although this was not statistically 
significant (p=0.10). Gender, Body Mass Index (BMI), Pig Ownership, Land ownership 
and Absolute Wealth index were also non-significant between hookworm positive and 
hookworm negative subgroups (p=0.6298, 0.8562, 0.6494, 0.2885 and 0.2629 
respectively). Religion was found to be significant (p=0.0278) and Christians and 
Traditionalists had the highest number of positives. Tribal identity was highly significant 
(p<0.0001), with almost all positive cases from the Konkomba and Chokose tribes, and 
no cases among the Mo tribe. The average household size was also significantly higher 
among children that were infected at baseline as compared to children that were 
uninfected (p=0.002). There was higher prevalence of infection among children who did 
not attend school at baseline (p=0.008) (Table 3). 
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Table 3. Demographic and Socioeconomic Indicators of the Study Population by 
Hookworm Infection Status at Baselinea 
  Hookworm Infection   
Characteristic % Positive (N = 57)b 
% Negative (N 
= 121)b pc 
Age (years) 9.13 ± 1.71 9.69 ± 1.71  0.1000 
Sex   0.6298 
    Female 47.37 (27) 51.24 (62)  
    Male 52.63 (30) 48.76 (59)  
Body Mass Index 16.65 ± 5.97 16.80 ± 2.85 0.8561 
Village   0.0002 
     Cheranda 8.77 (5) 27.27 (33)  
     Jato 78.95 (45) 47.93 (58)  
     Mahama 8.77 (5) 5.79 (7)  
     Tahiru 3.51 (2) 19.01 (23)  
Tribe     0.0001 
    Konkomba 68.42 (39) 53.72 (65)  
    Mo 0.00 (0) 17.36 (21)  
    Chokose 29.82 (17) 15.70 (19)  
    Other  1.75 (1) 13.22 (16)  
Absolute Wealth Index   0.2629 
     Low                            28.07 (16) 35.54 (43)  
     Medium 40.35 (23) 43.80 (53)  
     High 31.58 (18) 20.66 (25)  
Primary Religion     0.0278 
   Muslim 5.26 (3) 16.53 (20)  
   Christian 70.18 (40) 70.25 (85)  
   Traditional 21.05 (12) 8.26 (10)  
   Other 3.51 (2) 4.96 (6)  
Attends School   0.0077 
   Yes 89.47 (51) 98.35 (119)  
   No 10.53 (6) 1.65 (2)  
Average household size 13.82±6.78 10.48±7.82 0.0023 
Ownership of Land   0.2885 
    Yes 85.96 (49) 79.34 (96)  
    No 14.04 (8) 20.66 (25)  
Ownership of Pigs   0.6494 
    Yes 19.30 (11) 16.53 (20)  
    No 80.70 (46) 83.47 (101)  
aTable values are mean + SD for continuous variables and column % (N) for categorical 
variables 
bNumbers may not sum to total due to missing data and percentages may not sum to 100% 
due to rounding 
cp-value is for t-test (continuous variables) or x2-test (categorical variables) 
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Daily use of a toilet or latrine was also found to be highly statistically significant 
(<0.0001), with only one case among children that used a toilet or latrine daily (Table 4).  
Infection with another helminth infection (Trichuris or H. nana), daily shoe usage, and 
antiparasitic treatment in the last year were not found to be significantly associated with 
hookworm infection (p=0.6420, 0.3799, 0.8795 respectively).  
 
Table 4. Host Factors of the Study Population by Hookworm Infection Status at Baselinea 
  Hookworm Infection   
Characteristic 
% Positive (N = 
57)b 
% Negative (N = 
121)b pc 
Infection with another Helminth        0.6420 
    Yes 12.28 (7) 14.88 (18)  
    No 87.72 (50) 85.12 (103)  
Daily Shoe Usage   0.3799 
     Yes 78.95 (45) 84.30 (102)  
     No 21.05 (12) 15.70 (19)  
Daily Toilet or Latrine Use   <0.0001 
     Yes 1.79 (1) 31.40 (38)  
     No 98.25 (56) 68.60 (83)  
Antiparasitic treatment in the last 
year   0.8795 
     Yes    24.56 (14) 25.62 (31)  
     No 75.44 (43) 74.38 (90)  
aTable values are mean + SD for continuous variables and column % (N) for categorical 
variables 
bNumbers may not sum to total due to missing data and percentages may not sum to 100% 
due to rounding 
cp-value is for t-test (continuous variables) or x2-test (categorical variables) 
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f. Risk Factors for Hookworm Infection at Baseline 
 
Using the risk factors for infection, unadjusted logistic regression was used to identify 
variables for use in multivariate regression analysis. Odds ratios were adjusted for age, 
religion, body mass index (BMI), absolute wealth index, land ownership, infection with 
another helminth, and antiparasitic treatment in the last year. School attendance and daily 
toilet or latrine use were found to be risk factors for hookworm infection (p=0.0137 and 
0.0482 respectively), as was tribe. Specifically, being a member of the Konkomba or 
Chokose tribe was associated with an increased risk of having hookworm infection 
(p=0.0470 and 0.0439 respectively), while being a member of the Mo tribe was highly 
non-significant (p=0.9685) (Table 5). 
 
Table 5.  Risk Factors for Hookworm Infection at Baselinea 
Characteristic 
Adjusted Odds 
Ratio 95% Confidence Interval pc 
Male 0.863 0.391-1.906 0.7163 
Village 
(reference=Tahiru) 1.00  
      Cheranda 0.780 0.020-30.680 0.8942 
     Jato 0.356 0.013-9.597 0.5389 
     Mahama 0.857 0.031-23.420 0.9270 
Tribe 
(Reference=other) 1.00  
     Konkomba 28.090 1.045-755.150 0.0470 
    Mo 600443 1.102->999 0.0439 
    Chokose <0.001 <0.001->999 0.9685 
Household size 1.053 0.993-1.117 0.0829 
Pig Ownership 0.635 0.209-1.930 0.4230 
Daily Shoe Usage 1.881 0.684-5.176 0.2209 
Attends School              0.034  0.002-0.500 0.0137 
Daily Toilet or 
Latrine Use              0.011 <0.001-0.965 0.0482 
aAdjusted for all other variables in this model 
 
 
 
 
 
 
31 | P a g e  
 
g. Post-Treatment Demographic and Socioeconomic Assessment Based on Treatment 
Response 
 
Table 6. Demographic and Socioeconomic Indicators of the Treatment Population by Post-
Treatment Hookworm Infection Statusa 
  Hookworm Infection   
Characteristic % Positive (N = 21)b % Negative (N = 36)b pc 
Age (years) 8.95 +/- 1.82 9.38 +/- 1.71 0.3829 
Sex   0.9769 
    Female 47.37 (10) 47.22(17)  
    Male (91 )83065 52.78 (19)  
Body Mass Index 15.82+/- 1.83 17.13 +/- 7.38 0.3183 
Village   0.1212 
     Cheranda 0.00 (0) 13.89 (5)  
     Jato 95.24 (20) 69.44 (25)  
     Mahama 1.75 (1) 11.11 (4)  
     Tahiru 0.00 (0) 5.56 (2)  
Tribe     0.6923 
    Konkomba 66.67 (14) 69.44 (25)  
    Chokose 0.00 (0) 0.00 (0)  
    Mo 33.33 (7) 27.78 (10)  
    Other 0.00 (0) 2.78 (1)  
Absolute Wealth Index   0.7914 
     Low 28.57 (6) 27.78 (10)  
     Medium 33.33 (7) 41.67 (15)  
     High 38.10 (8) 30.56 (11)  
Primary Religion     0.4965 
   Muslim 9.52 (2) 2.78 (1)  
   Christian 71.43 (15) 69.44 (25)  
   Traditional 19.05 (4) 22.22 (8)  
   Other 0.00 (0) 5.56 (2)  
Attends School   0.2788 
    Yes 95.24 (20) 86.11 (31)  
    No 4.76 (1) 13.89 (5)  
Average Household Size 12.76 ± 6.76 14.44 ±8.41  0.4384 
Ownership of Land   0.2345 
   Yes 80.95 (17) 91.67 (33)  
   No 19.05 (4) 8.33 (2)  
Ownership of Pigs   0.1532 
  Yes 9.52 (2) 25.00 (9)  
  No 90.48 (19) 75.00 (27)  
aTable values are mean + SD for continuous variables and column % (N) for categorical 
variables 
bNumbers may not sum to total due to missing data and percentages may not sum to 100% 
due to rounding 
cp-value is for t-test (continuous variables) or x2-test (categorical variables)  
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Table 7. Host Indicators of the Treatment Population by Post-Treatment Hookworm Infection 
Statusa 
  Hookworm Infection   
Characteristic % Positive (N = 21)b % Negative (N = 36)b pc 
Infection with Another Helminth   0.1152 
    Yes 14.29 (3) 47.22(17)  
     No 85.71 (18) 66.67 (24)  
Daily Shoe Usage   0.6966 
     Yes 76.19 (16) 80.56 (29)  
     No 23.81 (5) 19.44 (7)  
Daily Toilet or Latrine Usage   0.4410 
     Yes 21 (100.00) 2.78 (1)  
     No 0 (0.00) 97.22 (35)  
Antiparasitic Treatment in the 
last year   0.5911 
     Yes    28.57 (6) 22.22 (8)  
     No 71.43 (15) 77.78 (28)  
aTable values are mean + SD for continuous variables and column % (N) for categorical 
variables 
bNumbers may not sum to total due to missing data and percentages may not sum to 100% 
due to rounding 
cp-value is for t-test (continuous variables) or x2-test (categorical variables)  
 
Post-treatment univariate analysis was conducted among children that received 
treatment and submitted a second fecal sample. This analysis was divided between children 
that were positive and children that were negative post-treatment, and no variables were 
found to be significantly associated with post-treatment response (Table 6 and 7).   
 
h. Cure Rate and Fecal Egg Reduction Rate 
Following examination of post-treatment isolates, the overall cure rate among infected 
children (n=57) was 63.2% (n=36) (Figure 11). The highest cure rates were observed in both 
Tahiru and Cheranda (100%), Mahama had a cure rate of 80% and the lowest cure rate was 
observed in Jato, where only 55% of children were cleared of infection following a single 
dose of the drug. 
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Figure 11: Community Variation in Response to Treatment 
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     Post-Treatment 36.84 
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Children at baseline had a higher mean egg count (442.53epg) than children that were 
positive following a single dose of albendazole (112epg) (Table 8). There was also more 
variation in egg count among children that were positive at baseline (standard deviation +/- 
909epg) and children that were positive post-treatment (191.97). All children that were 
positive post treatment (n=21) had a light infection (less than 1,999 eggs per gram).  
 
i. In Vitro Susceptibility of Hookworm Isolates 
       Egg hatch assays (EHA) were set up for samples that had counts greater than 10 
eggs/30µl, and incubated at room temperature for 24 hours. 20 pre-treatment samples and 4 
post-treatment samples had high enough egg counts to be used in the EHA. Figure 12 shows 
that for both pre- and post-treatment samples, as the concentration of albendazole increases, 
fewer eggs hatch. The median egg hatch rate at the highest concentration was similar at 
concentrations of 2, 5 and 10 µg/ml, and higher post-treatment at 1 µg/ml. However, these 
comparisons are limited due to the very low number of EHA data from post-treatment 
samples.  
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Figure 12: Susceptibility of Hookworm eggs to Albendazole at Increasing 
Concentrations Before and After Treatment 
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j. Identification of Hookworm Species using PCR: 
After setting up PCRs for all pre-treatment samples, a total of 39 yielded product during 
gel electrophoresis. After extracting all bands from the gel and submitting the purified 
products for sequencing, a 15/16 of the samples submitted for Necator americanus were 
confirmed through sequencing, while 0/23 products were confirmed for Ancylostoma 
duodenale. Based on these results, all confirmed isolates were positive for Necator 
americanus, and there were no confirmed Ancylostoma duodenale positive sequences. 
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IV. Discussion 
 
Epidemiology of Hookworm Infection 
 
Soil-transmitted nematodes (STNs) including Ascaris lumbricoides, Trichuris 
trichiura, and hookworms are estimated to infect one out of every two people in developing 
countries (Humphries D 2012). Hookworm is a STN estimated to infect 740 people around 
the world, with the highest prevalence in sub-Saharan Africa (29%), where nearly 200 
million people are infected (Humphries D 2012). STN infections have been targeted by a 
variety of control measures, including but not limited to health education, the introduction of 
latrines and better sanitary practices and chemotherapy (Albonico A, 1997).  In recent years, 
the World Health Organization has taken an active role in trying to lower the disease burden 
and DALYs associated with STN infections through the use of mass drug administration 
(MDA). Currently, the World Health Organization (WHO) recommends annual deworming 
in areas with more than a 20% prevalence of STN infection and bi-annual treatment to 
regions where prevalence is 50% or higher. Worldwide, a single dose of albendazole is one of 
the recommended treatments for hookworm infection.  
In Ghana, the prevalence of STN infections ranges from 40% in the central region to 
87% in the north (Humphries D 2012). Previous study on hookworm infection in Kintampo, 
Ghana reported a prevalence of 45% in 2007, 39% in 2010, and 57% in 2011 (Humphries D 
2012). This study found a lower prevalence of hookworm infection (32%) among the study 
population than in previous years. Similar to previous study in Kintampo, nearly every child 
(98.25%) harbored a light infection (1-1,999 eggs per gram) at baseline, and all children were 
lightly infected after treatment.  
Previous study in Kintampo found other intestinal parasites including Hymenolepis 
nana and Taenia spp. to infect 15% of the study population. Notably, Ascaris lumbricoides 
and Trichuris trichiura were not observed among any participants. This study found both H. 
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nana (12.92%) and T. trichiura (1.12%) to be present in the study population, while A. 
lumbricoides and Taenia spp. were absent.  
Human hookworm infection is primarily caused by two species of hookworm, 
Necator americanus and Anclystoma duodenale.(van Mens, Aryeetey et al. 2013) Infection 
with hookworms is endemic in many countries across sub-Saharan Africa. In Ghana, N. 
americanus is considered to be the predominant species, although studies have found that A. 
duodenale can coexist (de Gruijter, van Lieshout et al. 2005, van Mens, Aryeetey et al. 2013). 
Previous study in Kintampo in 2010 found most children to be infected with N. americanus 
(91.2%) (Humphries D 2013). Coinfection with A. duodenale to occur in a few cases (1.9%), 
and no isolated A. duodenale infections were observed during this study (Humphries D 
2013). This study reaffirmed previous studies, finding 16/16 sequences to be positive for 
Necator americanus following DNA extractions and PCR. Although no Ancylostoma 
duodenale were observed in isolates, this may be due to the low number of successful isolates 
sequenced (16/78), and further analysis of these samples is warranted.  
 
Risk Factors for Infection 
Given its association with rural poverty, risk factors for hookworm infection are 
consistently reported to be related to socioeconomic status. Limited access to clean water, 
sanitation and adequate health care, along with poor education provide an environment 
around which transmission can continue. Previous study in Kintampo identified education 
level, occupation, and malaria parasitemia to be risk factors for infection in 2007. A 2010 
study in Kintampo found pig ownership, parental occupation (farmer), larger household sizes, 
and not seeing a health care provider in the last year to be significantly associated with 
infection at baseline. This study found religion, village, tribal identity, not attending school, a 
larger household size, and not using a toilet or latrine daily to be statistically significant at the 
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0.05 level, indicating an association with helminth infection at baseline. Both school 
attendance and a larger household size are consistent with previous findings in Kintampo. 
Notably, this study was the first in Kintampo to identify religion, tribe and not using a toilet 
or latrine daily to be significantly associated with hookworm infection at baseline.  
 Following analysis with Multivariate Logistic Regression, risk factors for infection at 
baseline were identified. It was found that children that attended school had an Odds Ratio 
(OR) of 0.03 (p=0.01), indicating that school attendance was protective for infection with 
hookworm. This finding is consistent with previous study in Kintampo, which identified a 
higher education level as a protective factor for infection. Having daily access to a latrine was 
associated with a decreased risk for infection (OR=0.01), and children that had daily access 
were approximately ten times less likely to be infected than children that did not have daily 
access (p=0.049). While this was not found previously in Kintampo, lack of access to latrines 
has been found to be a risk factor for infection in previous studies (Chongsuvivatwong, Pas-
Ong et al. 1996, Olsen, Samuelsen et al. 2001). 
This was the first time that questions about tribal identity were asked to study 
participants in Kintampo. Findings demonstrated that being a member of the Konkomba or 
Mo tribes was associated with infection at baseline (p=0.047 and 0.044 respectively), while 
being a member of the Mo tribe was highly protective, with no cases of hookworm at 
baseline (p=0.969). 
 
Treatment Efficacy 
A single dose of albendazole (400mg) is frequently used in mass drug administration 
(MDA) campaigns as the primary drug recommended for the treatment of hookworm 
infection. Studies have found cure rates following administration to range from 33-95% and 
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the fecal egg count reduction rate to range from 64% to 100% (Keiser J 2010, Humphries D 
2013, Samuel, Degarege et al. 2014).  
Previous study in Kintampo found that cure rates (CR) after administration of a single 
dose of albendazole were shown to decrease over time, as 61% of the study population 
treated at baseline cleared infection in 2007, 43% cleared infection in 2010, and 39.5% 
cleared infection in 2011 (Humphries D 2012). Similarly, the mean fecal egg count reduction 
rate (FECR) fell from 81.5% in 2007 to 70.9% by 2011. This study found a higher cure rate 
(63.2%) and fecal egg count reduction rate (90.7%) than in previous years. While these data 
show the drug to be more effective than previously thought, there was a large degree of 
variation in treatment response at the community level.  
Data from 2011 indicated that there was large variation in treatment response between 
villages. None of the treated children from Jato were cleared of infection after treatment and 
the mean FECR among children treated was only 1.2% (Humphries D 2012). In comparison, 
the cure rate in neighboring village Cheranda was 81.8%, with a mean FECR of 96.3% 
(Humphries D 2012). This study was conducted as a follow-up in order to further examine 
these differences in treatment response. 
During previous years, a sample of children were enrolled from each community to 
provide an estimate of the disease burden in each community. This study enrolled every 
available child from both Jato and Cheranda, along with children from Mahama and Tahiru. 
The prevalence of infection varied by community, with 45% of children positive for 
hookworm in Jato, and 8.0% of children positive in Tahiru. The Fecal Egg Reduction Rates 
(FECR) and Cure rates (CR) were highest in Cheranda and Tahiru (100%) and lowest in Jato, 
where only 55% of children were cured of infection, and 87.5% of children experience a 
reduction in their egg counts. As was seen in Cheranda, Mahama, and Tahiru, nearly every 
child responded to therapy and was cleared of infection after a single dose of the drug (CR= 
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91.67%). In Jato, a village that neighbors both Cheranda and Mahama, 44.44% of children 
were positive for infection after treatment (CR=55.56%).  Together, these data provide 
evidence that the effectiveness of albendazole treatment varies widely at the community 
level. These findings are consistent with data from the 2011 field study in Jato and Cheranda, 
which similarly observed differences in treatment response by community. 
While these findings demonstrate a wide degree of variability in baseline prevalence 
and treatment response between villages, it is important to note that each community is not 
independent. Interestingly, all five cases of hookworm in Cheranda were in homes that were 
on the outskirts of town, nearest Jato. While this study did not take GPS coordinates of each 
home, the fact that each positive case from Cheranda came from locations nearest Jato is 
important to keep in mind.  
 
Study Limitations 
 
Limitations of this study include the use of the Kato-Katz technique to diagnose 
infection. The Kato-Katz is recommended by the WHO as a useful technique that provides an 
indirect measure of worm burden (Montresor A. 1998). However, its use is expected to 
underestimate the disease burden within a community (Montresor A. 1998). This is especially 
problematic for samples that have been left out, as hookworm eggs rapidly deteriorate in 
stool (Montresor A. 1998). This deterioration could result in an underestimation of the burden 
of disease, due to the fact that it becomes less likely that a positive sample will be read 
correctly. To lessen this risk, samples were quickly returned to the laboratory after being 
collected, and slides were read within a few hours of collection.  
Similarly, the effectiveness of the drug could have played a role in the response to 
treatment. However, every precaution was taken in ensuring that a viable drug was obtained, 
and that each child took the medication correctly. Doses of albendazole were obtained from 
the Kintampo Municipal Hospital, and trained assistants administered the drug to each 
42 | P a g e  
 
infected child. Each child was observed taking the medication, so as to eliminate the 
possibility that the infected child didn’t take the drug.   
Other limitations of the study include the use of the questionnaire, which may not 
have assessed health risk factors for infection. Data was not collected on several potential risk 
factors including rash history, health care access in the last year, or malaria co-infection. 
These factors have been found to play a role in infection status and were not assessed over 
the course of this study. Recall bias may have played a role in response to several questions, 
which could have played a role in the identification of risk factors for infection. Missing data 
or inaccuracies in reporting were especially problematic when acquiring birth dates for each 
child to confirm their age. The age of each child could not always be confirmed, and data 
relied on the parent reporting the correct age of their child.  
 
 
 Conclusions 
   
Ultimately, these data demonstrate the need for more targeted approaches to the 
treatment of helminth infections, as variable responses are observed within each community. 
Findings from Jato suggest that in some communities, chemotherapy alone is not enough. In 
contrast, data from other communities demonstrate that within the right setting, therapeutic 
approaches can make significant contributions to decreasing worm burden, at least in the 
short term. Yearly or bi-yearly treatment of infected children also increases the chance that a 
change in parasite susceptibility will occur. This is especially problematic in communities 
like Jato, where a lack of sanitary practices, access to latrines, and access to health education 
coincide with high rates of reinfection. As such, those that are cleared of infection with MDA 
are likely to become reinfected – thereby negating the purpose of the treatment. Given these 
differences in treatment response, these data suggest the need for more targeted interventions 
in order to further control helminth infections in the developing world. Control measures such 
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as health education or providing access to latrines could make a more substantial impact in 
communities like Jato, where MDA has been implemented, and where infection rates 
continue to be high among school children. Data from this study further supports the need for 
new approaches to combat the disease burden posed by helminth infections in much of the 
developing world.  
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VI. Appendices 
 
a. Appendix 1: Ghana Questionnaire, Summer 2013 
 
 
 
 
 
 
 
 
 
IDENTIFICATION 
 
CHILD NAME __________________________________________________________________ 
 
DATE OF BIRTH 
____________________________(DDMMMYYYY)_________________________ 
 
AGE __________________________________________________________________________ 
 
SEX □ MALE    1    □ FEMALE    2 
HEIGHT _______________(XX.XX cm)_____________________________________________ 
 
WEIGHT _______________________(XX.XX KG)____________________________________ 
 
SCHOOL/CLASS________________________________________________________________ 
 
CHILD ID #_____________________________________________________________________ 
 
HEAD OF HOUSEHOLD _________________________________________________________ 
 
RESPONDENT NAME____________________________________________________________ 
 
RELATIONSHIP OF RESPONDENT TO CHILD_______________________________________ 
 
HOUSE NUMBER…………………………………...…………………………………………….. 
 
COMMUNITY.…….…………………………………………………………………….................. 
 
GPS LATITUDE AND LONGITUDE……………………………………………………………… 
 
INTERVIEWER NAME ___________________________________ NUMBER _____________ 
 
INTERVIEWER NAME ___________________________________ NUMBER _____________ 
 
 
 
 
QUESTIONNAIRE ANSWERS REVIEWED ______________ (DDMMYYYY Date)  
 
                                                                           ______________ (Initials) 
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1.  SOCIOECONOMIC INDICATORS 
NO. QUESTIONS AND FILTERS CODING CATEGORIES ENTER # 
 
1.1 
 
What is the main material of the floor? 
 
 
NATURAL FLOOR...…..……………...…1 
CEMENT FLOOR…...……….…………...2 
TILE FLOOR……………………..……….3 
 
 
 
1.2 
 
What is the main material of the walls? 
 
Mudbrick ………………………………….1 
Brick ……………………………………….2 
Other ……………………………………….66 
 
 
1.3 
 
What is the main material of the roof? 
 
Thatch ……………………………………..1 
Metal ………………………………………2 
Other ………………………………………66 
 
 
1.4 
 
What type of fuel does the household mainly use for 
cooking? 
 
 
ELECTRICITY...…………………………….1 
NATURAL GAS……………………………..2 
BIOGAS……………………………...............3 
KEROSENE…..……………………………...4 
CHARCOAL ..…………………….................5 
FIREWOOD/STRAW …………………….....6 
DUNG..…………………………………….....7 
OTHER______________________________66  
                            (SPECIFY) 
 
 
 
1.5 
 
 
Does your household have: 
1.5a 
1.5b 
1.5c 
1.5d 
1.5e 
1.5f 
 
 
 
 
                                                   YES           NO 
ELECTRICITY………….…..….1                2 
RADIO.…………….……....…...1                2 
 
TELEVISION..…………..……...1                2 
 
TELEPHONE..………….……....1                2 
 
REFRIGERATOR………………1                2 
 
DVD/VCR  .………….……........1                2 
 
 
 
1.6 
 
Does any member of the household own: 
 
 
 
 
                                                   YES          NO 
BICYCLE……………………….1               2 
MOTORCYCLE/SCOOTER…...1               2 
CAR/TRUCK.………………......1               2 
 
 
 
1.7 
 
Does any member of the household own agricultural 
land? 
 
 
YES………………………………………….1 
NO..………………………………………….2 
DON’T KNOW……………...………….......88 
 
 
 
1.8 
 
Does any member of the household own at least one: 
 
1.8a 
1.8b 
1.8c 
1.8d 
1.8e 
1.8f 
1.8g 
1.8h 
 
 
                                                  
                                                     How many? 
COW………………..…………- 
HORSE…………………..……- 
DONKEY ……………………..- 
GOAT………………..……..…- 
SHEEP………………..……….- 
POULTRY…...…….….………- 
DOG……………….….……….- 
PIG…………………..….……..- 
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1.9 
 
Does anyone in the household own a savings account? 
 
                                      YES        NO        DK 
BANK…………………..1            2           88 
CO-OPERATIVE.......….1            2           88 
 
 
 
1.10 
 
How far is the household from the nearest health 
facility? 
 
 
 
 
LESS THAN 1KM………………………...…1 
BETWEEN 1 AND 5KM...……………….….2 
BETWEEN 5 AND 10KM……………….......3 
GREATER THAN 10KM..………………......4 
DON’T KNOW………………………………88 
 
 
 
1.11 
 
How many people in the household? 
 1.11a 
1.11b 
1.11c 
1.11d 
1.11e         
 
Total number __________________ 
         < 5 yrs             _______________ 
         6-11 yrs           _______________ 
         12-15 yrs         _______________ 
         Women > 15     _______________ 
         Men > 15        ________________ 
 
 
1.12 What is the primary religion of the household? 
 
Muslim 
Christian 
Traditional 
Other 
 
1.13 What tribe do you belong to?   
 
 
 
 
 
2. HOUSEHOLD WATER SOURCES 
NO. QUESTIONS AND FILTERS CODING CATEGORIES ENTER # 
 
2.1 
 
 
What is the main source of water for members of your 
household? 
 
 
 
 
 
 
 
 
 
  
PIPED WATER…………….…...10 
DUG WELL....…………..…..…. 11 
WATER FROM A SPRING….... 12 
RAINWATER…..……………… 13 
SURFACE WATER….………… 14 
OTHER…………………………. 66 
                              (SPECIFY) 
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4. EXPOSURE/DISEASE PREVENTION 
NO. QUESTIONS AND FILTERS CODING CATEGORIES ENTER # 
 
4.1 
 
Has any member of your household had deworming 
medication in the past year?   
 
YES…………………………………….…….1 
NO..…………………………………………..2 
DON’T KNOW………………………..…....88 
 
 
4.2 
 
Does the child own shoes? 
 
YES…………………………………….…….1 
NO..……………………………………….….2 
DON’T KNOW……………...……………....88 
 
 
4.3 
 
If yes, does the child wear shoes daily? 
 
Almost all the time every day………………1 
Some of the time every day…………...……2 
Some of the time, not every day……………3 
Rarely……………………………………….4 
DON’T KNOW……………...……..……....88 
 
 
 
 
3. TOILET FACILITIES AND GARBAGE 
NO. QUESTIONS AND FILTERS CODING CATEGORIES ENTER # 
 
3.1 
 
 
What kind of toilet facility do members of the 
household use? 
 
3.1a 
3.1b 
3.1c 
3.1d 
3.1e 
3.1f 
3.1g 
 
 
 
                                                   YES           NO 
 
 
FLUSH OR POUR...…….…..….1                2 
PIT LATRINE...…….……..........1                2 
COMPOST...………..…………..1                2 
BUCKET.………………….…....1                2 
BUSH OR FIELD………...…….1                2 
RIVER…………………………..1                2 
OTHER____________________________ 66 
                              (SPECIFY) 
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THA
NK 
YOU for all of your help.  We are very grateful for your time!
5. PARASITE TREATMENT 
LINE NO. 
ANTI-PARASITIC 
HISTORY 
ANTIPARASITIC 
TREATMENT 
 
TREATMENT SOURCE 
 
Antiparasitic treatment in 
the past year? 
See treatment codes below See treatment source codes below 
(1) (2) (3) (4) 
 
 
Index Child 
 
  YES     NO 
 
   1          2 
 
 
 
Head of Household 
  
   1          2 
  
 
Mother or Caregiver 
 
  
   1          2 
  
 
03 FROM TABLE 6 
 
  
   1          2 
  
 
04 FROM TABLE 6 
  
   1          2 
  
 
05 FROM TABLE 6 
  
   1          2 
  
 
06 FROM TABLE 6 
 
  
   1          2 
  
 
07 FROM TABLE 6 
 
  
   1          2 
  
 
TREATMENT CODES 
 
ALBENDAZOLE…………1                MEBENDAZOLE……………………………2 
PYRANTEL………………3                OTHER ANTI-PARASITIC______________4 
DON’T KNOW..................88                                                                (SPECIFY) 
 
 
TREATMENT SOURCE CODES 
 
HOSPITAL…….....................1                      LOCAL CLINIC…................... 2 
PHARMACIST…...................3                      LOCAL HEALER….................4 
FAMILY MEMBER…...........5                      DRUG STORE…................…..6 
OTHER_________________ 66                    DON’T KNOW………………88 
                      (SPECIFY) 
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b. Appendix 2: Egg Extraction Protocol 
 
Purpose:  Extract eggs from fecal matter; bring eggs to a known concentration for EHA and/or 
concentrate into 200µl to freeze for gDNA extraction.   
Items needed PER SAMPLE: 
1. Feces 
2. 100 ml 0.9% NaCl 
3. 40 ml 0.015% Brij-35 
4. 40 ml 2.18M NaNO3 
5. 3 x 250 ml centrifuge bottles 
6. 2 x 50 ml FALCON centrifuge tubes 
7. 1 sheet 4”x4” gauze 
8. 1 funnel 
9. 40 ml of  H2O 
10. 1x 80 µm filter 
11. 1x 20 µm filter 
12. Filter apparatus unit 
13. 200 ml H2O in a flask or beaker 
 
PROCEDURE 
1. Add ~100 ml of 0.9% NaCl directly to sample in stool collection cup 
    OR 
2. Put needed grams of feces into 250 ml centrifuge bottle and add ~100ml 0.9% NaCl 
3. Shake vigorously 
4. Filter over a single layer of gauze placed in a funnel to remove large particulate 
5. COLLECT FILTRATE IN CLEAN 250 ML bottle 
6. Squeeze gauze to get as much liquefied sample as possible 
7. Centrifuge @500g for 5 minutes 
8. Carefully decant supernatant-DISCARD into beaker-EGGS IN PELLET 
9. Resuspend pellet in 0.015% Brij-35 measured to 40 ml mark on conical 
10. Shake vigorously to resuspend pellet 
11. Spin @500g for 5 minutes 
12. CAREFULLY open bottle and discard supernatant into beaker-EGGS IN PELLET 
13. Add 40 ml with NaNO3 (2.18 M, 1.185 specific gravity); GENTLY resuspend pellet by 
inverting 
14. Transfer to a 50 ml FALCON centrifuge tube 
15. Spin @500g for 10 minutes 
-WHILE SPINNING SET UP FILTRATION APPARATUS WITH 80 µm 
FILTER 
16.  Decant top 10 ml into a beaker or flask containing 200 ml water – swirl mix 
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17. Pour solution over 80 µm filter in filtration apparatus– apply gentle suction if necessary 
-EGGS WILL FLOW THROUGH THE 80 µm FILTER 
18. Remove used filter from apparatus; Position clean 20 µm filter 
19. Pour flow-through over 20 µm filter- EGGS WILL BE TRAPPED ON 20 µm FILTER 
20. FOLD the 20 µm filter into a 50ml conical containing 40 ml of water; Shake to release 
eggs trapped on filter>> remove filter paper. 
21. Spin @ 500g for 5 minutes 
22. Let stand for 90 minutes 
23. Gently aspirate down to approximately 1 ml >> EGGS IN BOTTOM OF SOLUTION 
24. Resuspend gently and count 20 ul of suspension- adjust to 50 eggs in 100 µl for EHA 
25. Dispense 10 wells of 50 eggs/100 µl each for EHA 
26. High speed (1000g?) spin remaining eggs to pellet; remove water leaving 200 µl 
27. Freeze -20°C. 
 
 
 
 
 
SOLUTIONS: ALL SOLUTIONS REQUIRE HIGH QUALITY OR DISTILLED WATER 
 
0.9% NaCl: per 1 liter 
9 grams of NaCl per 1000 ml H2O 
 
0.015% Brij-35: per liter 
0.5 ml of 30% Brij-35 per 1000 ml H2O 
 
NaNO3 (2.18 M, 1.185 specific gravity): per liter 
185 grams per 1000 ml H2O 
 
NEEDED FOR 150 SAMPLES: 
 
6 liters 0.9% NaCl; 54 grams NaCl 
6 liters 0.015% Brij-35; 3 ml 30% Brij-35 
2.25 liters 2.18M NaNO3; 416.25 grams NaNO3 
150-300 50 ml FALCON centrifuge tubes 
300 x 15 ml FALCON centrifuge tubes 
150 sheets gauze 
1 funnel 
20 ml of  H2O 
150 x 80 µm filter 
150 x 20 µm filter 
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c. Appendix 3: Baerman Funnel Set-up 
  
1. Mix feces with bone charcoal (http://www.ebonex.com/) so that there is an even distribution. 
We have found a 5:1 (charcoal:feces) ratio is optimal. If soil is used it should be sterilized. The 
mixture is moistened with room temperature distilled water is applied so that the mixture is 
wetted; water droplets should not be visible and placed into a 150 x 20mm falcon sterile petri 
dish (falcon #1013). The prepared dish is incubated at 26°C in the dark for 12-14 days.  A beaker 
of water is kept in the incubator to humidify (if necessary). 
 
2. The plate is removed from the incubator after 12-14 days. The mixture is placed within a 
large kimwipe that has been folded in half over a mesh screen/sieve to create a pouch. Care is 
taken to contain the mixture within the kimwipe to avoid loss of sample and potential charcoal 
contamination of later steps. The kimwipe serves as a filter for the migrating larvae emerging 
from the mixture. 
 
3. Water is preheated to 37-40°C. A funnel is set up so that it hangs vertically. Tubing has been 
secured to the bottom of the funnel and a clamp is in place.  The kimwipe/screen/sample is 
placed inside a funnel such that the diameter of the screen fits within the middle diameter of the 
funnel.  The preheated water is poured slowly over the top of the 
sample until the surface is submerged by 1-2 cm of water and 
the tubing below is full. Again, care is taken to keep the 
charcoal mixture within the kimwipe as the larvae do not 
survive well in dirty water. The air bubble that develops in the 
tubing over the top of the clamp is “burped” to remove.  
 
4. The funnel apparatus is left at room temperature (22°C) for 
approx. 18 hours. For funnels set up with ~1000ml water--the 
bottom 2 X 50 mls of water in the tubing is decanted into 2 
sterile 50 ml conicals by opening the clamp slightly. The sample 
is left undisturbed at room temperature on the bench for at least 
an hour to allow the emerged larvae to settle to the bottom. The 
top 45ml of liquid is then carefully removed and clean water is 
added to the remaining 5ml. This washing step is repeated 2 
times to remove any contaminated water.  
 
5. The final remaining 5 ml containing the larvae are visually 
assessed to confirm the presence of larvae. The volume is 
increased with 1X BU buffer (50 mM Na2HPO4, 22 mM KH2PO4, 70 mMNaCl; pH 6.8) for 
storage (10L3/µl). 
 
10X BU Buffer= 500 mM Na2HPO4, 220 mM KH2PO4, 700 mMNaCl; pH 6.8; filter sterilize 
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d. Appendix 4: EGG HATCH ASSAY (EHA) 
 
Purpose:  Calculate the percent hatching of individual samples in a panel of albendazole 
concentrations (0, 0.1, 1, 2, and 5 µg/ml) to screen for resistant phenotypes. 
 
Supplies: 
6 - 50ml conicals for Albendazole solutions 
 
Procedure: 
 Prepare a 5 mg/ml solution of albendazole resuspended in methanol (MeOH) 
 Prepare by dissolving 0.2 grams in 40 ml MeOH 
  *NOTE* albendazole will form a milky solution- NOT CLEAR 
 Prepare a 20 µg/ml solution by adding 200 µl of 5 mg/ml solution to 50 ml H2O 
 
 Then: 
Prepare the following solutions: 
0 µg/ml…………………………………….Add 200 μl of methanol to 50 ml of water 
2 µg/ml……………………….……………Add 5 ml of 20 µg/ml solution to 45 ml water  
4 µg/ml………………………………….…Add 10 ml of 20 µg/ml solution to 40 ml water  
10 µg/ml…………………………………..Add 25 ml of 20 µg/ml solution to 25 ml water 
20 µg/ml…………………………………..Use 20 µg/ml solution 
 
 For each sample to be tested add 100 µl per well of the above solutions in duplicate to wells of 
a 96 well plate.   
PLATE SET UP: *NOTE*  Final concentrations to be tested reflect the dilution of 
adding 100 µl of extracted hookworm eggs to the above solutions 
 Add 100 µl of appropriate stock ABZ solution to each well. 
 Add 100 µl (50 eggs) of the egg sample to be tested to each well. 
 
***Final volume per well= 200 µl*** 
 
Subject 
1 
0 
µg/ml 
Repl 1 
0 
µg/ml 
Repl 2 
1 
µg/ml 
Repl 1 
1 
µg/ml 
Repl 2 
2 
µg/ml 
Repl 1 
2 
µg/ml 
Repl 2 
5 
µg/ml 
Repl 1 
5  
µg/ml 
Repl 2 
10 
µg/ml 
Repl 1 
10 
µg/ml 
Repl 2 
Subject 
2 
0 
µg/ml 
Repl 1 
0 
µg/ml 
Repl 2 
1 
µg/ml 
Repl 1 
1 
µg/ml 
Repl 2 
2 
µg/ml 
Repl 1 
2 
µg/ml 
Repl 2 
5 
µg/ml 
Repl 1 
5  
µg/ml 
Repl 2 
10 
µg/ml 
Repl 1 
10 
µg/ml 
Repl 2 
***CONFIRM THE ADDITION OF EGGS TO EACH WELL USING A 
MICROSCOPE*** 
 
 Incubate the sample plate at 27°C for 48 hours. 
 Record the number of larvae and the number of unhatched eggs for each treatment. 
 Calculate % hatching as follows:  
Number of larvae 
(Number of unhatched eggs + Number of larvae)    X 100= % hatching 
